Several low-fidelity DNA polymerases have recently been discovered that are able to bypass DNA lesions during DNA synthesis in vitro. The efficiency and accuracy of lesion bypass is, however, both polymerase and lesion specific. For example, in vitro studies revealed that human DNA polymerase (Pol) is unable to insert a base opposite a cis-syn thymine-thymine dimer or cisplatin adduct, yet can bypass some DNA lesions such as abasic site and acetylaminofluorene-adducted guanine in an error-prone manner. More importantly, Pol is able to bypass benzo 
C
hromosomal DNA in living organisms is continually exposed to a vast variety of damaging agents from exogenous and endogenous sources. Most DNA lesions are repaired by one of multiple DNA repair pathways that are found in all prokaryotic and eukaryotic cells (1) . However, repair is often slow; for example, between the two major DNA lesions produced by UV-irradiation, photoproducts that generate substantial distortions in the DNA double-helix structure are rapidly detected and repaired, but cyclobutane pyrimidine dimers (CPDs) that distort the DNA to a lesser extent are repaired much more slowly (2) . When the replication complex encounters a persisting lesion, it often stalls at the site because replicative DNA polymerases have a high selectivity for the correct normal base and cannot insert any base opposite most lesions. To avoid an aberrant cessation of the cell cycle caused by such a blockage of DNA replication, the stalled DNA polymerase needs to be transiently replaced by another DNA polymerase that is capable of bypassing the lesion (3) . Because such lesion-bypass enzymes do not have a proofreading function, translesion synthesis (TLS) is inevitably accompanied by mutations at a frequency that depends on the type of DNA damage and the particular polymerase(s) involved.
Recently, a number of previously unrecognized DNA polymerases, which are likely to have evolved specially to carry out TLS, have been identified in both prokaryotes and eukaryotes (3) (4) (5) (6) (7) . These enzymes are collectively designated the Y-family DNA polymerases (8) , because they share multiple common motifs in their primary sequences that are distinct from those of the previously known A-, B-, C-, and X-families of DNA polymerases (9) . Nevertheless, they retain tertiary structures conserved in most DNA polymerases, right-hand architecture with fingers, palm, and thumb subdomains (ref. 10 and references therein). Human cells have multiple Y-family enzymes, among which Pol bypasses thymine-thymine (T-T) CPDs efficiently and accurately in vitro, in most cases inserting two As opposite the T-T dimers (11, 12) . Pol cannot, however, bypass past (6-4) photoproducts, which distort the DNA structure more than CPDs. Patients with the variant form of xeroderma pigmentosum (XP-V) lack Pol (13, 14) . As a consequence they are highly mutable by UV light and predisposed to sunlight-induced skin cancer (15) . These facts clearly demonstrate a crucial role for Pol in the response to UV damage. Another human Y-family enzyme, Pol, exhibits a different specificity for lesion bypass in vitro (16 -21) . Pol bypasses abasic sites and acetylaminofluorene adducts in an error-prone manner, but is not able to bypass either T-T CPDs or (6-4) photoproducts or cisplatin adducts (17) .
Benzo[a]pyrene (B[a]P) and other polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental carcinogens that are present in cigarette smoke and air pollutants (1, 22) . B[a]P is thought to be responsible for the p53 mutations detected in the lung tumors of smokers (23) . B[a]P and other PAHs are converted to active mutagens and carcinogens when metabolized by intracellular processes mediated by the arylhydrocarbon receptor (AhR; ref. 24) . Activated B[a]P introduces bulky adducts into cellular DNA, predominantly at the 2-amino position of guanine and less frequently at the 6-amino position of adenine, and these lesions can, like UV-induced DNA damage, be repaired by nucleotide excision repair (NER). Under in vitro experimental conditions, Pol bypasses B[a]P-adducted guanines with low efficiency and fidelity (25, 26) , but Pol efficiently bypasses these lesions in a mostly error-free manner by inserting C opposite the bulky lesion (18, 27) . We have recently shown that expression of the mouse Polk gene is, at least partially, under the control of AhR, being induced by 3-methylcholanthrene, a PAH (28) . These findings have suggested that Pol might participate in the bypass of DNA damage produced by B[a]P and other PAHs. Furthermore, Pol expression is elevated in human lung cancer tissues compared with their matched normal tissue counterparts, whereas no apparent correlation was found between Pol expression level and smoking history of the 29 patients examined (29) .
To determine any biological significance from these findings related to Pol and B[a]P, we constructed mutants from a mouse embryonic stem (ES) cell line with both copies of the Polk gene disrupted, and examined such mutants for sensitivity to various DNA-damaging agents, including B[a]P. We show here that Polk-deficient mutant cells are hypersensitive to B[a]P and accumulate more B[a]P-induced mutations than the parental cells. Thus, our results provide strong evidence that Pol does play an important role in accurately bypassing DNA lesions induced by B[a]P in mammalian cells.
Materials and Methods
Construction of the Mouse Polk Gene Targeting Vector. A phage genomic DNA library from a TT2 mouse ES cell line (an F 1 embryo from a cross between a C57BL͞6 female and a CBA male; ref. 30 ) was screened with a Polk-cDNA fragment. Phage clones that hybridized to the probe were subcloned into the vector pZERO2 (Invitrogen). Genomic structure of the mouse Polk gene was compared with the human POLK sequence (see AB040752 to AB040765 in the GenBank͞DDBJ͞EMBL DNA database). To construct pTKLS1 for targeting the mouse Polk gene, the 5-kb SpeI-XhoI fragment from intron 3 to intron 4 and the 3-kb SmaI-BamHI fragment in intron 6 were inserted into the SalI and XhoI site of the pLNTK vector (31), respectively (see Fig. 1b ). clones were identified by DNA blot analysis using a radiolabeled 1-kb genomic DNA fragment upstream of the 5Ј SpeI site as a probe (see Fig. 1b ES clones were cultured in medium containing 1.8 mg͞ml G418 for 8 days, and resistant clones were analyzed by DNA blotting. Of the 43 clones thus obtained, four clones (A71 and A72, derivative of no. 48, and F21 and F22, derivative of no. 151) contained only the targeted Polk allele. Absence of the wild-type Polk allele was confirmed by PCR using the primer set of mmPolk5-5 (5Ј-GCTACTTCGAATTACCATGCAAGG-3Ј) and mmPolk5-3 (5Ј-CTCCTGTACTCACAGCTCTATATTT-GTCAAA-3Ј) that amplify endogenous Polk exon5, or of G3 (5Ј-GGGCCAGCTCATTCCTCCACTCA-3Ј) and mmPolkSm (5Ј-GCAGGGTTGGAAACAGCCACAC-3Ј) that amplify the neomycin-resistance gene. The absence of Pol protein was also confirmed by immunoblotting using anti-Pol antibodies (28) . Cell Survival Assay. The sensitivity of Polk-targeted ES cells to ionizing radiation, UV, and B[a]P was determined by measuring the colony-forming efficiency of cells treated over a range of doses. Cells were grown on feeder plates supplied with ES medium and maintained by passaging every third day to keep logarithmic-phase growth. Trypsinized cells were suspended in ES medium or PBS and exposed to ionizing or UV irradiation. Control and irradiated cells were plated on feeder plates. Before B[a]P treatments, cells were allowed to adhere to feeder plates for 6 h and then treated with the drug for 20 h. B[a]P (Nacalai Tesque, Kyoto) was prepared in DMSO and activated by the S-9 fraction of rat liver homogenates (Japan Immunoresearch Laboratories, Gunma, Japan). Control cells were also treated with S-9 (0.1% DMSO͞0.1% S-9). After treatment, cells were grown for 10-14 days on feeder plates in ES medium containing 1 mM caffeine, fixed, stained, and counted. All experiments were carried out in triplicate; data points are indicated as mean with standard error.
Construction of Polk

B[a]P-Induced Mutation Frequency and Mutation Spectrum at the Hprt
Locus. B[a]P-treated cells were cultured for 8 days to express the Hprt-defective phenotype. After this expression period, 5 ϫ 10 5 cells were plated on a gelatinized 10-cm dish (without feeder cells) in the presence of ES medium containing 40 M 6-thioguanine (6-TG, Nacalai Tesque). Several dilution cultures were also plated without 6-TG medium to calculate the colonyforming efficiency. After selection for 2 weeks, 6-TG-resistant (6-TG R ) colonies were counted and cloned. 6-TG R cells were amplified and total RNA was isolated. RT-PCR and direct sequencing were performed as described (35) .
Results
Construction of Polk-Deficient Cells. The mouse Polk and human POLK genes have a similar structure that includes 15 exons (Fig.  1a and our unpublished data) . Exons 5 and 6 include the conserved motif sequences II and III, respectively, which are essential for enzymatic activity (16) . A targeting plasmid, pTKLS1, was constructed by replacing a 10-kb genomic fragment, including exons 5 and 6 of the Polk gene, with the PGKneo gene (see Materials and Methods). The plasmid also contains the HSV-tk gene for counterselection against nonspecific integrants by ganciclovir. pTKLS1 was transfected into TT2 ES cells by electroporation and cells resistant to both G418 (300 g͞ml) and ganciclovir (1 mM) were selected. One hundred and sixty clones were selected and characterized by Southern blotting and PCR analysis (Fig. 1 c and d) . The Polk ϩ/Ϫ clones thus identified were cultured in ES medium containing 1.8 mg͞ml G418 to select for clones with higher resistance to the drug. Forty-three clones survived the higher G418 dose and four of these clones (A71 and A72 from no. 48, and F21 and F22 from no. 151) had a disruption in both copies of the Polk gene ( Fig. 1 c and d) . Pol protein was undetectable in the Polk Ϫ/Ϫ cells by Western blot analysis (Fig. 1e) . (Fig. 2a) . Another wild-type mouse ES cell line, F1͞1 (32) , and an Xpa Ϫ/Ϫ derivative of this cell line, 176-20, both grew at a slightly slower rate than TT2 cells or cells derived from TT2 (Fig. 2a) . Xpa Ϫ/Ϫ cells are defective in NER and consequently very sensitive to various DNA-damaging agents (33) . The data shown in Fig. 2a had similar levels of sensitivity to x-rays; in contrast, Polk Ϫ/Ϫ cells were slightly but significantly sensitive to UV. Polk Ϫ/Ϫ cells were much less sensitive to UV than were NER-deficient Xpa Ϫ/Ϫ cells. The UV sensitivity associated with the Polk Ϫ/Ϫ phenotype is a somewhat unexpected result, because previous in vitro results (16) (17) (18) (19) (Fig. 2d) . This sensitivity approached the 5-fold hypersensitivity of Xpa Ϫ/Ϫ cells, which are completely unable to remove B[a]P adducts. In most cases, the B[a]P sensitivity of Polk Ϫ/Ϫ cells was restored to normal when cells were transfected with a clone expressing wild-type Pol. A typical result with one such case (821-23) is shown in Fig. 2d . The results shown in Fig.  2d provide very strong evidence for a major role for Pol in the response of mammalian cells to B[a]P damage.
Properties of Polk-Deficient
Cells. The Polk-deficient cells and the parental Polk-proficient cells proliferated at similar rates on feeder plates
Frequencies of B[a]P-Induced Mutations in Polk-Proficient and -Deficient Cells. In view of the striking hypersensitivity of Polk
Ϫ/Ϫ cells to killing by B[a]P, we next investigated their response to its mutagenic effects. B[a]P-induced mutagenesis was studied in
Polk-proficient and -deficient cells by measuring the incidence of mutations at the Hprt locus that confer 6-TG resistance (Fig. 3a) . The frequency of spontaneous 6-TG R mutations was very low (Ͻ10 Ϫ6 ) in the wild-type and Polk Ϫ/Ϫ cells, and much higher in Xpa Ϫ/Ϫ cells (7 ϫ 10
Ϫ6
). As expected, Xpa Ϫ/Ϫ cells were highly prone to B[a]P-induced mutagenesis. When exposed to 0.5 M B[a]P, Xpa Ϫ/Ϫ cells had a mutation frequency of 1.3 ϫ 10 Ϫ4 , which did not increase significantly with higher doses. In Polk Ϫ/Ϫ cells, the mutation frequency was Ϸ1 ϫ 10 Ϫ6 in cells exposed to 0.5 M B[a]P and it increased to Ϸ1 ϫ 10 Ϫ4 in cells exposed to 10 M B[a]P (Ͼ100-fold higher than the spontaneous mutation frequency). At saturation, the mutation frequency was similar in Xpa Ϫ/Ϫ and Polk Fig. 3a and also see Table 1 , which is published as supporting information on the PNAS web site, www.pnas.org). These data show that Pol protects cells not only from the lethal effects of B[a]P, but also from its mutagenic effects.
B[a]P-Induced Mutations Generated in Polk-Proficient and -Deficient
Cells. To gain further insight into the mutations induced by B[a]P in the presence and absence of Pol, we analyzed the mutation spectrum in the wild-type and Polk Ϫ/Ϫ cells treated with B[a]P. About 40 clones each resistant to 6-TG were isolated from the wild-type and Polk Ϫ/Ϫ cells treated with 10 M B[a]P, and Hprt mRNAs were amplified by RT-PCR for direct DNA sequencing. With one exceptional case, single or multiple alterations were identified in the Hprt-cDNA sequence analyzed, and the results are summarized in Fig. 3 b and c (also see Table 2 , which is published as supporting information on the PNAS web site). Base-substitution mutations predominated over frameshift (FS) mutations in both cell types; the ratio of base-substitution to FS mutations was 31:3 and 35:5 in wild-type and Polk Ϫ/Ϫ cells, respectively (see Table  2 ). Such base substitutions occurred at G about twice more frequently than at A in wild-type cells (20 vs. 11 ), but they occurred predominantly at G in Polk Ϫ/Ϫ cells (31 vs. 4) . Furthermore, whereas G-to-T transversions and A-to-G transitions were observed almost equally in wild-type cells (9 and 8, respectively, of the total 31 mutations), G-to-T transversions were overwhelmingly predominant in Polk Ϫ/Ϫ cells (28 of 35). Another feature of the mutation spectra is that the majority of mutations can be attributed to adduct in the nontranscribed strand. The ratio of mutations from the nontranscribed strand vs. the transcribed strand is 19:12 in the wild-type cells and 27:8 in Polk Ϫ/Ϫ cells. This result implies that the bulky adducts on the transcribed strand are repaired more rapidly than those on the nontranscribed strand by the transcription-coupled repair mechanism (36 -38) . From these results, we conclude that Pol plays a crucial role in correctly bypassing dG-N 2 -B[a]P-7,8-diol-9,10-epoxide (BPDE) adducts, the major products generated by B[a]P, and that in Polk-deficient cells another TLS enzyme(s) is involved in the bypass in an error-prone manner, generating mostly G-to-T transversions. -BPDE by Pol was highest when A was incorporated opposite the lesion, but the value was less than 10 Ϫ5 of that for C incorporation opposite a nondamaged template by Pol (26) . This result is in sharp contrast to the situation with T-T CPD; Pol synthesizes DNA opposite a CPD T-T dimer with the same accuracy and efficiency as opposite the nondamaged DNA template in vitro (11, 12) . Pol appears to have a structure adapted for bypassing CPD and it can also bypass various other lesions correctly at reduced efficiencies (20, 39, 40) , but dG-N 2 -BPDE adducts seem to be very poor substrates for the enzyme to bypass correctly. More recently, Rechkoblit et al. (41) compared the bypass of (ϩ)-and (Ϫ)-trans-dG-N 2 -BPDE in the same sequence context by human Pol, Pol, Pol, and yeast Pol, although not quantitatively by steady-state kinetic experiments. The overall bypass of either of the two stereoisomers was higher with Pol than with Pol; however, Fins appeared to be to the contrary. Pol inserted a base indiscriminately, especially A in preference to others, opposite either one of the above two dG-N 2 -BPDE adducts, whereas Pol inserted the correct C predominantly at lower efficiency. Neither Pol nor yeast Pol, either alone or in combination, was effective in TLS past the dG-N 2 -BPDE adducts.
The human REV1 protein, another Y-family enzyme, was shown to insert C opposite (ϩ)-trans-dG-N 2 -BPDE in a sequence context (5Ј-CG*C-3Ј), whereas not extending any further from the inserted site (42) . The Fins was 0.15 of that for C insertion opposite the nondamaged template. This value is much higher than the corresponding value of 2.8 ϫ 10 Ϫ3 for Pol (27) . Although no experimental evidence is currently available to support a role for REV1 in the bypass of BPDE-adducts in vivo, it is possible that the correct bypass of dG-N 2 -BPDE adducts might be carried out in vivo not only by Pol alone as discussed above, but also by the two-polymerase two-step mechanism, i.e., the insertion of C opposite the lesions by REV1 and subsequent extension by Pol (42, 43) . Mutagenic bypass of dG-N 2 -BPDE adducts in wild-type cells may be because of sequential action of Pol and Pol (43) . Pol inserts A, G, or T more frequently than C opposite dG-N 2 -BPDE adducts, but extending further less effectively (41) , and subsequent extension of the misincorporated bases by Pol may lead to generating base-substitution mutations. The increased proportions of G-to-T transversions in the mutations among the survivors of B[a]P-treated Polkdeficient ES cells (Fig. 3c ) may reflect in vivo bypass of dG-N 2 -BPDE adducts that depends mainly on Pol. It is not known whether human Pol can insert a base opposite the dG-N 2 -BPDE adducts or extend from an inserted base by other enzyme(s) because the human Pol enzyme has not yet been purified.
Until recently, it has not been known which enzyme(s) is involved in the bypass of dA-N 6 -BPDE adducts, the minor products generated by B[a]P. A very recent paper by Rechkoblit et al. (41) reported that Pol bypassed (ϩ)-trans-dA-N 6 -BPDE adduct but not (Ϫ)-trans-dA-N 6 -BPDE adduct in vitro, whereas Pol was completely blocked by both of the lesions. They also showed that neither human Pol nor yeast Pol, either alone or in combination, was effective in TLS past the dA-N 6 -BPDE adducts, although Pol was able to insert T opposite (Ϫ)-transdA-N 6 -BPDE but not opposite (ϩ)-trans-dA-N 
Ϫ4
, although further extension was relatively poor. Again, it seems possible that Pol might be involved in catalyzing extension from a base inserted opposite dA-N 6 -BPDE adducts by Pol.
Our finding that Polk-deficient ES cells show moderate sensitivity to UV radiation (Fig. 2c) was unexpected, because all of the in vitro data (16) (17) (18) (19) have indicated that Pol by itself cannot bypass T-T CPD or (6-4) photoproducts. Our in vitro experiment (17) indicated that, at a high enzyme concentration, Pol inefficiently inserted one base opposite the 3ЈT of a T-T (6-4) photoproduct, but could not subsequently insert a base opposite the 5ЈT of the lesion. At the same enzyme concentration, synthesis by Pol was completely blocked at one base before 3ЈT of a T-T CPD. However, a recent paper (44) has shown that Pol can efficiently catalyze extension from G or A (but not from C or T) inserted opposite the 3ЈT of a T-T CPD, whereas it does not extend from any base inserted opposite the 3ЈT of a T-T (6-4) photoproduct. Our in vivo results shown in Fig. 2c , taken together with these in vitro data, suggests that Pol plays a role in bypass of UV-induced damage, albeit a minor one compared with that of Pol, and its role might become more important when Pol is absent, as in XP-V cells.
In conclusion, our results provide strong evidence that Pol plays a major role in protecting cells from the genotoxic effects of B[a]P, and, by implication, of other PAHs. This finding is also consistent with our earlier observations that the promoter region of the mouse Polk gene contains two copies of the arylhydrocarbon receptor binding site and that Pol is induced on exposure of mice to a polycyclic hydrocarbon (28) .
